Vivera Pharmaceuticals. .Areum Bio ya rigaya shine babban mai rarrabawar CareStart™ COVID-19 gwajin antigen na gaggawa daga masana'antar New Jersey Access Bio, kuma za ta nemi ƙarfafa aikin sarkar sa ta hanyar babban cibiyar sadarwa na masu samar da lafiya da ƙungiyoyin Vivera.
Kamar yadda jami'o'i, kasuwanci, kamfanonin jiragen sama, da wuraren jama'a ke amfani da gwaje-gwaje na yau da kullun a matsayin wani ɓangare na komawa makaranta, aiki, balaguro, da yarjejeniyar jam'iyya, samun ingantaccen gwajin COVID-19 ya kasance babban abin buƙata.Ingancin gwajin gwajin antigen na CareStart ™ da aka ba da izini na Point-of-Care (POC), haɗe tare da faffadan iyawar rarrabawar Vivera, zai tabbatar da samun sauƙin samun hanyoyin gwajin ganowa cikin sauri.
Amurka ta cimma manyan nasarori wajen shawo kan kololuwar cutar, amma saboda yawan allurar rigakafin ba su da inganci kuma barazanar sabbin bambance-bambancen na ci gaba da fitowa a duk duniya, yana da matukar muhimmanci kasar ta ci gaba da bin ka'idojin gwajin COVID-19 don rage yaduwar .Haɗin gwiwar rarraba tsakanin Vivera, Areum Bio da Access Bio zai sauƙaƙe gwaji da sauri da sauri.A matsayin mai ba da izini mai ba da izini na gwajin saurin antigen CareStart™, Vivera yana da niyyar faɗaɗa ɗaukar hoto don tabbatar da cewa masu ba da lafiya da marasa lafiya sun sami damar yin gwajin gaggawa don taimakawa tabbatar da amincin al'ummarmu.
"Wannan haɗin gwiwar haɗin gwiwar alama alama ce ta sabon ƙawancen dabarun ga Vivera," in ji Paul Edalat, Shugaba da Shugaba na Vivera Pharmaceuticals."Kamfanin yana da darajar yin aiki tare da Areum Bio da Access Bio don samar da sauri kuma ingantaccen gwajin COVID-19 na EUA ga ƙungiyoyin kiwon lafiya da marasa lafiya a duk faɗin ƙasar.Ta hanyar fadada iyakokin gwaji, Vivera za ta tabbatar da cewa abokan aikinmu da marasa lafiya, musamman ma al'ummomin marasa galihu da suka dogara da mu na iya samun sakamako mai ma'ana. "
Dr. Jong Kim, shugaban Areum Bio ya ce "Wannan wata kyakkyawar dama ce ga Areum Bio don yin haɗin gwiwa tare da sanannen kamfanin harhada magunguna Vivera don rarrabawar CareStart™ COVID-19 da sauri na gwajin antigen a duk faɗin ƙasar," in ji Dr. Jong Kim, shugaban Areum Bio.“Ta hanyar wannan haɗin gwiwar, ta yin amfani da sha’awarmu da ƙwarewarmu, za mu iya samar da na’urorin gwaji cikin sauri da aminci ga al’ummomi a duk faɗin ƙasar cikin lokaci da inganci.Mun yi imani da cewa ko da mafi m kayan aikin likita, Su kuma ba su da amfani sai dai idan an rarraba wa marasa lafiya da suke bukatar su.A Areum Bio, mun yi imani da gaske cewa za mu yi nasara ne kawai lokacin da sabbin na'urorinmu suka isa marasa lafiya da masu samarwa kuma suka cimma burinsu.Saboda haka, a koyaushe muna aiki tuƙuru., Don isar da samfuranmu ga abokan ciniki cikin sauri da inganci.”
Ta hanyar haɗin gwiwar rarraba dabarunsu, Vivera, Areum Bio, da Access Bio suna fatan tallafawa ƙasar ta dawo cikin aminci da kwanciyar hankali ta hanyar haɓaka samar da ingantacciyar gwaji mai inganci a cikin ƙasa baki ɗaya.
CareStart ™ COVID-19 Gwajin Antigen gwajin gwaji ne na kai tsaye da ake amfani da shi don gano ƙimar furotin na nucleocapsid daga SARS-CoV-2 a cikin nasopharyngeal ko samfuran swab na hanci waɗanda aka tattara kai tsaye daga waɗanda ake zargi da COVID-19 ana zargin mutanen da ke da COVID-19 da COVID-19 lokacin da su. Ma'aikatan kiwon lafiya suna yin gwaje-gwaje biyu a cikin kwanaki biyar na farko na bayyanar cututtuka, ko daga mutanen da ba su da alamun cututtuka ko wasu dalilai na annoba, aƙalla sa'o'i 24 tsakanin gwaje-gwaje Kuma ba fiye da sa'o'i 48 ba.
Gwaji yana iyakance ga dakunan gwaje-gwajen da aka ba da izini a ƙarƙashin Gyaran Gyaran Laboratory Clinical (CLIA) na 1988, 42 USC §263a, kuma waɗannan dakunan gwaje-gwaje sun cika buƙatun don yin matsakaici, babba, ko keɓe gwaje-gwaje masu rikitarwa.An ba da izinin yin amfani da gwajin a cikin kulawa (POC), wato, wuraren kula da marasa lafiya waɗanda ke aiki ƙarƙashin takaddun keɓewar CLIA, takaddun yarda, ko takaddun shaida.
Don ƙarin bayani, da fatan za a ziyarci ku ko tuntuɓe mu akan LinkedIn, Facebook, Twitter ko Instagram.
Areum Bio, LLC amintaccen mai rarraba kayan aikin likita ne kuma ya kafa amintacciyar haɗin gwiwa tare da Access Bio, Inc. Areum Bio reshen Ivy Pharma Inc. ne mai hedikwata a New Jersey.Kamfanin yana aiki tare da abokan kasuwanci da yawa kuma ya kafa tashoshi na rarrabawa a duniya.Baya ga tarihin rarrabawarta na shekaru 15 a cikin Amurka, yana da Don taimakawa, Areum Bio shima ya tashi don taimakawa cikin sauri rarraba ingantattun kayan gwajin coronavirus ta hanyar babbar hanyar sadarwar sa.Kamfanin ya himmatu wajen ci gaba da inganta lafiyar jama'a da jin dadin jama'a ta hanyar samar da ingantattun na'urorin gwaji masu inganci a kan lokaci.
Access Bio, Inc. sanannen masana'anta ne na gano cutar da ke cikin New Jersey, har yanzu yana mai da hankali kan bincike, haɓakawa da samar da cututtukan cututtuka.Access Bio ta himmatu wajen yin rigakafi da farkon gano cututtuka masu yaduwa ta hanyar bincike, haɓakawa da kera gwaje-gwajen gaggawa na in vitro, na'urorin biosensors da samfuran gano ƙwayoyin ƙwayoyin cuta.Dangane da mafi girman buƙatu da yuwuwar yin nagarta, kamfanin yana haɗin gwiwa tare da abokan haɗin gwiwa a duk duniya, gami da Gidauniyar Bill da Melinda Gates, Hukumar Lafiya ta Duniya, da Asusun Kula da Yara na Majalisar Dinkin Duniya.
Lokacin aikawa: Jul-01-2021